CAD 0.53
(1.92%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 12.43 Million CAD | -321.61% |
2022 | 3.91 Million CAD | 106.11% |
2021 | 1.89 Million CAD | -69.13% |
2020 | 6.15 Million CAD | 365.71% |
2019 | 1.32 Million CAD | 652.15% |
2018 | 175.63 Thousand CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 897 Thousand CAD | -53.35% |
2024 Q2 | -2.97 Million CAD | -431.88% |
2024 Q3 | 1 Million CAD | 133.69% |
2023 Q4 | 1.92 Million CAD | -61.9% |
2023 Q1 | 2.99 Million CAD | 622.46% |
2023 FY | -8.67 Million CAD | -321.61% |
2023 Q2 | 3.34 Million CAD | 11.94% |
2023 Q3 | 5.04 Million CAD | 50.75% |
2022 FY | 3.91 Million CAD | 106.11% |
2022 Q3 | 1.95 Million CAD | 130.0% |
2022 Q4 | 414 Thousand CAD | -78.82% |
2022 Q1 | 695 Thousand CAD | 1728.95% |
2022 Q2 | 850 Thousand CAD | 22.3% |
2021 Q3 | -1.2 Million CAD | -190.74% |
2021 FY | 1.89 Million CAD | -69.13% |
2021 Q4 | 38 Thousand CAD | 103.15% |
2021 Q2 | 1.32 Million CAD | -23.53% |
2021 Q1 | 1.73 Million CAD | -33.18% |
2020 FY | 6.15 Million CAD | 365.71% |
2020 Q1 | 843 Thousand CAD | 220.6% |
2020 Q2 | 1.52 Million CAD | 81.14% |
2020 Q3 | 1.18 Million CAD | -22.72% |
2020 Q4 | 2.6 Million CAD | 120.42% |
2019 Q3 | 533 Thousand CAD | -55.4% |
2019 Q1 | 545.56 Thousand CAD | 1144.25% |
2019 Q2 | 1.19 Million CAD | 119.04% |
2019 Q4 | -699 Thousand CAD | -231.14% |
2019 FY | 1.32 Million CAD | 652.15% |
2018 Q2 | - CAD | 0.0% |
2018 Q3 | 228 Thousand CAD | 0.0% |
2018 FY | 175.63 Thousand CAD | 0.0% |
2018 Q4 | -52.24 Thousand CAD | -122.91% |
2018 Q1 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Aurora Cannabis Inc. | 131.46 Million CAD | 90.543% |
Avicanna Inc. | 6.65 Million CAD | -86.703% |
Cardiol Therapeutics Inc. | -248.35 Thousand CAD | 5105.738% |
Crescita Therapeutics Inc. | 10.36 Million CAD | -19.954% |
Knight Therapeutics Inc. | 152.65 Million CAD | 91.856% |
MediPharm Labs Corp. | 5.85 Million CAD | -112.331% |
OrganiGram Holdings Inc. | 35.07 Million CAD | 64.554% |
Canopy Growth Corporation | 80.88 Million CAD | 84.629% |
Willow Biosciences Inc. | -659 Thousand CAD | 1986.495% |
Auxly Cannabis Group Inc. | 21.27 Million CAD | 41.571% |